| Literature DB >> 22818666 |
Ester Ballana1, Eva Riveira-Munoz, Christian Pou, Vanessa Bach, Mariona Parera, Marc Noguera, José R Santos, Roger Badia, Maria Casadellà, Bonaventura Clotet, Roger Paredes, Miguel Angel Martínez, Christian Brander, José A Esté.
Abstract
Homozygosity for a 32 bp deletion in CCR5 (CCR5-Δ32/Δ32) is associated with strong resistance against HIV-1 infection. Several HLA types have been associated to improved viral control and/or delayed progression to AIDS. We report a unique HIV-1 infected individual homozygous for CCR5-Δ32/Δ32 and carrier of HLA-A*2402 and HLA-B*5701. In comparison with earlier data and although a replication competent virus has been isolated, the patient presents better immune status, response to treatment and disease evolution, which may be related to the control exerted by HLA class I restricted T cell immunity. Importantly, the accumulation of protective factors does not warrant a complete protection to HIV infection and the subsequent life-long treatment.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22818666 DOI: 10.1016/j.imbio.2012.06.012
Source DB: PubMed Journal: Immunobiology ISSN: 0171-2985 Impact factor: 3.144